These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3485718)

  • 1. Kinetic analysis of Ia expression on T cells in patients with systemic lupus erythematosus.
    Kitani A; Hara M; Hirose T; Norioka K; Hirose W; Kawagoe M; Nakamura H
    J Clin Lab Immunol; 1986 Feb; 19(2):59-63. PubMed ID: 3485718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
    Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
    Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Gergely P
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased peripheral blood Ia positive T cells and their effect on autologous mixed lymphocyte reaction in chronic active liver disease.
    Fukui K; Kakumu S; Murakami H; Kuriki J; Yoshioka K; Sakamoto N
    Clin Exp Immunol; 1984 Oct; 58(1):90-6. PubMed ID: 6236920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin.
    Shiratsuchi H; Tsuyuguchi I
    Clin Exp Immunol; 1984 Aug; 57(2):271-8. PubMed ID: 6331920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies.
    Synkowski DR; Provost TT
    J Rheumatol; 1983 Dec; 10(6):920-4. PubMed ID: 6607342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions.
    Raziuddin S; Danial HB; Kelley M
    Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.
    Fox RI; Fong S; Sabharwal N; Carstens SA; Kung PC; Vaughan JH
    J Immunol; 1982 Jan; 128(1):351-4. PubMed ID: 6976376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
    Katagiri T
    Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy in expression ability of Tac antigen and Ia determinants defined by monoclonal antibodies on activated or cultured cord blood T lymphocytes.
    Yokoi T; Miyawaki T; Yachie A; Ohzeki S; Taniguchi N
    J Immunol; 1982 Oct; 129(4):1441-5. PubMed ID: 6980936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP; Miescher PA; Zubler RH
    J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
    Niwa Y; Sakane T; Shingu M; Yokoyama M
    J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of activated lymphocytes on the regulation of hematopoiesis: suppression of in vitro granulopoiesis and erythropoiesis by OKT8+ Ia- T cells induced by concanavalin-A stimulation.
    Harada M; Odaka K; Kondo K; Nakao S; Ueda M; Matsue K; Mori T; Matsuda T
    Exp Hematol; 1985 Oct; 13(9):963-7. PubMed ID: 2931299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
    Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
    Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.
    Sagawa A; Abdou NI
    J Clin Invest; 1978 Oct; 62(4):789-96. PubMed ID: 308952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.